FDA Inspection 1008069 — CooperVision, Inc.

CooperVision, Inc. — FEI 1314956

The FDA completed an inspection of CooperVision, Inc. on April 13, 2017 in Scottsville, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 13, 2017
Fiscal Year
2017
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Scottsville, NY (United States)

Citations

IDCFRDescription
313021 CFR 820.100(a)Lack of or inadequate procedures